Italia markets close in 6 hours 10 minutes

ILMN Dec 2024 220.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,40000,0000 (0,00%)
In data: 12:54PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,4000
Aperto3,4000
Denaro2,5000
Lettera6,3000
Prezzo d'esercizio220,00
Scadenza2024-12-20
Min-Max giorno3,4000 - 3,4000
Contratto - Min-MaxN/D
Volume1
Open Interest20
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera